Roluperidone clinical trials
Also written MIN-101.
How each study uses roluperidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the roluperidone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses roluperidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruitingPhase 3Minerva NeurosciencesNCT07565428Written as Roluperidone
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of SchizophreniaCompletedPhase 1Minerva NeurosciencesNCT06107803Written as Roluperidone 64 mg
- Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of SchizophreniaCompletedPhase 3Minerva NeurosciencesNCT03397134Written as Roluperidone 32 mg
- A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy SubjectsCompletedPhase 1Minerva NeurosciencesNCT03038646Written as MIN-101
- A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive MetabolizersCompletedPhase 1Minerva NeurosciencesNCT03072056Written as MIN-101
- Pharmacokinetic Study of MIN-101 in Healthy SubjectsCompletedPhase 1Minerva NeurosciencesNCT02232529Written as MIN-101
- Study of CYR-101 in Patients With SchizophreniaCompletedPhase 2Cyrenaic PharmaceuticalsNCT00861796Written as CYR-101
Codes
What other systems call roluperidone · ClinicalTrials.gg INT000858
- MeSH (NLM) C000625557roluperidoneOne source NLM
- UNII (FDA) 4P31I0M3BFROLUPERIDONEConfirmed FDA, NLM, Wikidata
- Wikidata Q25100536roluperidoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166772RoluperidoneOne source FDA
- DrugBank DB13080One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000625557 | roluperidone | One source NLM |
| UNII (FDA) | 4P31I0M3BF | ROLUPERIDONE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q25100536 | roluperidone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166772 | Roluperidone | One source FDA |
| DrugBank | DB13080 | — | One source Wikidata |
Also registered as roluperidone hydrochloride (UNII WFL7TF8DTP).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.